Faks

Based in Paris, France, Faks develops a centralized software platform that facilitates communication and operational exchanges between pharmacists, pharmacy groups, and pharmaceutical laboratories. The company provides a mobile application and desktop interface designed to manage claims, handle expired products, process sales transactions, and optimize daily supplier relationships. Operating on a subscription-based business model through its Faks Konnect service, the platform is currently utilized by a broad network of 18,000 pharmacies. The enterprise has demonstrated steady market adoption since its initial release, reaching its 1,000th pharmacy milestone in March 2021 and expanding to 3,000 active locations by February 2022. Management projects the software company will secure over 1,500 dedicated Faks Konnect subscribers by the end of 2025. Backed by venture capital firm FJ Labs, Faks was founded in 2020 by Corentin Geoffray and Felix Pignard.

Faks appears to refer to two distinct entities in public records: (A) FAX Capital / FAX Capital Corp., a Toronto-based investment company (sometimes styled “FAX” or “Fax”), and (B) Faks (often shown as “Faks” or “Faks.co”), a Paris-based communications SaaS startup focused on pharmacists. I’ll provide two short, parallel profiles so you can pick the one you meant; tell me which to expand on if you want more detail.

High-Level Overview

• FAX Capital (investment firm): FAX Capital is a Toronto-based investment company focused on long‑term asset management of high‑quality investments across public and private markets; it describes itself as an active, patient owner that invests across the capital structure and works collaboratively with portfolio companies to add value[2][3]. Historical records show the corporate vehicle was formerly God’s Lake Resources Inc. and changed its name to FAX Capital Corp. in December 2018[1][2].
  - Faks (Paris, SaaS — portfolio company): Faks is a Paris-based communications platform that builds a specialized SaaS product to streamline communication for pharmacists and pharmacy teams; it has raised seed/early funding (Seedtable reports total raised ≈ $5.4M across rounds) and presents itself as solving sector-specific workflow & communication problems for pharmacies[4].

Origin Story

• FAX Capital (firm): The corporate lineage traces to an older company incorporated in 1923 that later repositioned from mining exploration to investment activities and rebranded as FAX Capital Corp. in December 2018; the firm presents itself as run by experienced partners focused on long‑term value creation and alignment with portfolio management[1][2][5].
  - Faks (company): Founded in Paris by entrepreneurs addressing pharmacy communications and operational inefficiencies, Faks pivoted to a vertical SaaS communications product for pharmacists and has shown early traction reflected in seed-stage funding and investor backing (Seedtable summary)[4].

Core Differentiators

• FAX Capital (firm)
• Long-term, patient capital and active ownership model focused on both public and private assets[2].
  - Willingness to invest across capital structures and put its own capital alongside partners[2].
  - Background transition from earlier mining activities to concentrated asset management—suggesting flexibility in strategy evolution[1][2].
  - Faks (company)
• Vertical focus: communications built specifically for pharmacists and pharmacy teams, aiming to replace generic messaging tools with workflow-aware features[4].
  - Early funding and investor network for growth in Europe’s pharmacy/health-tech verticals[4].

Role in the Broader Tech / Finance Landscape

• FAX Capital: Operates in the long‑term asset management and private equity space for small–mid sized companies, a segment benefiting from fragmented markets where active owners can create operational improvements and consolidation value[2][5]. The firm’s timing aligns with investors allocating to active, hands‑on capital as public markets oscillate.
  - Faks (SaaS): Rides the vertical‑SaaS and health‑tech trends where specialized tools for regulated professionals (pharmacists) can capture high retention and expansion within a defined market; timing matters as pharmacies digitize operations and seek secure, compliant communication tools[4].

Quick Take & Future Outlook

• FAX Capital: Likely to continue deploying patient capital into a mix of public and private holdings while emphasizing hands‑on value creation; future growth depends on deal flow in small/mid buyouts and the firm’s ability to demonstrate portfolio exits or marked value uplift[2][5].
  - Faks: If it keeps scaling customer acquisition in France and other European markets, the company can leverage vertical specialization to expand product suites (inventory integrations, telepharmacy, compliance features) and justify higher ARPU; success hinges on execution, regulatory compliance, and integration partnerships with pharmacy systems[4].

If you want a single, expanded profile (firm vs. company), tell me which one and I’ll produce a longer write‑up with more dated milestones, leadership names, financing rounds, and cited sources.